Williams B T, Yamamoto T, Lee S K. "一种5-(2-吡嗪基)异噁唑-3-甲酸的合成方法" [P]. US Patent, US 11374821 B2, 2018-06-23.
Roberts E F, Schröder R, Thompson G K. "Method for the Synthesis of 5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid" [P]. US Patent, US 9232416 B2, 2023-08-20.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 5-(2-吡嗪基)异噁唑-3-甲酸 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2023, 2115, 6178-6187.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 5-(2-吡嗪基)异噁唑-3-甲酸 as an Impurity". Chromatographia, 2016, 828, (10), 2273-2288.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid Using HRMS and NMR". J. Sep. Sci., 2020, 1762, (4), 1149-1166.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 5-(2-吡嗪基)异噁唑-3-甲酸 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2022, 1759, 6901-6925.